Study protocol for a randomized controlled trial: prophylactic swallowing exercises in head-and-neck cancer patients treated with (chemo)radiotherapy (PRESTO trial).


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
02 Mar 2020
Historique:
received: 31 10 2019
accepted: 13 02 2020
entrez: 4 3 2020
pubmed: 4 3 2020
medline: 29 12 2020
Statut: epublish

Résumé

Dysphagia is a common and serious complication after (chemo)radiotherapy (CRT) for head-and-neck cancer (HNC) patients. Prophylactic swallowing exercises (PSE) can have a significantly positive effect on post-treatment swallowing function. However, low adherence rates are a key issue in undermining this positive effect. This current randomized trial will investigate the effect of adherence-improving measures on patients' swallowing function, adherence and quality of life (QOL). This ongoing trial will explore the difference in adherence and swallowing-related outcome variables during and after PSE in HNC patients performing the same therapy schedule, receiving different delivery methods. One hundred and fifty patients treated in various hospitals will be divided into three groups. Group 1 performs PSE at home, group 2 practices at home with continuous counseling through an app and group 3 receives face-to-face therapy by a speech and language pathologist. The exercises consist of tongue-strengthening exercises and chin-tuck against resistance with effortful swallow. The Iowa Oral Performance Instrument and the Swallowing Exercise Aid are used for practicing. Patients are evaluated before, during and after treatment by means of strength measurements, swallowing and QOL questionnaires. Since low adherence rates undermine the positive impact of PSE on post-treatment swallowing function, there is need to develop an efficient PSE protocol maximizing adherence rates. ISRCTN, ID: ISRCTN98243550. Registered retrospectively on 21 December 2018.

Sections du résumé

BACKGROUND BACKGROUND
Dysphagia is a common and serious complication after (chemo)radiotherapy (CRT) for head-and-neck cancer (HNC) patients. Prophylactic swallowing exercises (PSE) can have a significantly positive effect on post-treatment swallowing function. However, low adherence rates are a key issue in undermining this positive effect. This current randomized trial will investigate the effect of adherence-improving measures on patients' swallowing function, adherence and quality of life (QOL).
METHODS METHODS
This ongoing trial will explore the difference in adherence and swallowing-related outcome variables during and after PSE in HNC patients performing the same therapy schedule, receiving different delivery methods. One hundred and fifty patients treated in various hospitals will be divided into three groups. Group 1 performs PSE at home, group 2 practices at home with continuous counseling through an app and group 3 receives face-to-face therapy by a speech and language pathologist. The exercises consist of tongue-strengthening exercises and chin-tuck against resistance with effortful swallow. The Iowa Oral Performance Instrument and the Swallowing Exercise Aid are used for practicing. Patients are evaluated before, during and after treatment by means of strength measurements, swallowing and QOL questionnaires.
DISCUSSION CONCLUSIONS
Since low adherence rates undermine the positive impact of PSE on post-treatment swallowing function, there is need to develop an efficient PSE protocol maximizing adherence rates.
TRIAL REGISTRATION BACKGROUND
ISRCTN, ID: ISRCTN98243550. Registered retrospectively on 21 December 2018.

Identifiants

pubmed: 32122397
doi: 10.1186/s13063-020-4171-0
pii: 10.1186/s13063-020-4171-0
pmc: PMC7053144
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

237

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Curr Opin Otolaryngol Head Neck Surg. 2017 Jun;25(3):175-181
pubmed: 28266944
J Phys Ther Sci. 2015 Dec;27(12):3631-4
pubmed: 26834320
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):210-9
pubmed: 22014959
Dysphagia. 2018 Jun;33(3):337-344
pubmed: 29052051
Dysphagia. 2012 Dec;27(4):538-49
pubmed: 22456699
Dysphagia. 2015 Aug;30(4):392-403
pubmed: 25840788
Arch Otolaryngol Head Neck Surg. 2004 Apr;130(4):401-8
pubmed: 15096421
Laryngoscope. 2008 Jan;118(1):39-43
pubmed: 17989581
Arch Phys Med Rehabil. 2005 Aug;86(8):1516-20
pubmed: 16084801
Cancer. 2007 May 1;109(9):1914-22
pubmed: 17377917
Dysphagia. 2015 Jun;30(3):315-20
pubmed: 25840786
Dysphagia. 2017 Aug;32(4):487-500
pubmed: 28444488
Support Care Cancer. 2014 Mar;22(3):595-602
pubmed: 24141700
Head Neck. 2017 Oct;39(10):1943-1961
pubmed: 28766850
Dysphagia. 2013 Mar;28(1):11-23
pubmed: 22572839
BMJ Open. 2017 Mar 27;7(3):e014167
pubmed: 28348190
Otolaryngol Head Neck Surg. 2013 Dec;149(6):878-84
pubmed: 23981953
Oral Oncol. 2018 Feb;77:125-130
pubmed: 29362118
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):923-9
pubmed: 21095074
J Clin Oncol. 2006 Jun 10;24(17):2636-43
pubmed: 16763277
Control Clin Trials. 2000 Oct;21(5 Suppl):188S-94S
pubmed: 11018574
Ann Otol Rhinol Laryngol. 2015 May;124(5):351-4
pubmed: 25358607
Dysphagia. 2017 Apr;32(2):279-292
pubmed: 27844152
Dysphagia. 2012 Mar;27(1):46-52
pubmed: 21424584
Physiotherapy. 2016 Jun;102(2):127-35
pubmed: 26821954
Support Care Cancer. 2017 Nov;25(11):3417-3423
pubmed: 28573486
Phys Ther. 1993 Nov;73(11):771-82; discussion 783-6
pubmed: 8234458
Dysphagia. 1997 Spring;12(2):63-7
pubmed: 9071804
Laryngoscope. 2004 Aug;114(8):1362-7
pubmed: 15280708
J Am Geriatr Soc. 2016 Feb;64(2):417-24
pubmed: 26804715
Laryngoscope. 2006 Jun;116(6):883-6
pubmed: 16735913
J Gerontol A Biol Sci Med Sci. 2011 Apr;66(4):452-8
pubmed: 21300744
Trials. 2015 Sep 04;16:395
pubmed: 26340887
Dysphagia. 2017 Apr;32(2):327-336
pubmed: 27848021
Dysphagia. 2007 Jul;22(3):251-65
pubmed: 17457549
Dysphagia. 2018 Apr;33(2):227-233
pubmed: 28965209
JAMA Otolaryngol Head Neck Surg. 2013 Nov;139(11):1127-34
pubmed: 24051544
J Am Geriatr Soc. 2005 Sep;53(9):1483-9
pubmed: 16137276
J Psychosom Res. 1995 Apr;39(3):315-25
pubmed: 7636775
Arch Phys Med Rehabil. 2007 Feb;88(2):150-8
pubmed: 17270511
J Med Internet Res. 2014 Mar 06;16(3):e74
pubmed: 24610383
Clin Exp Otorhinolaryngol. 2013 Sep;6(3):117-26
pubmed: 24069513
Oncology. 2008;74(1-2):25-30
pubmed: 18544956
Head Neck. 2015 Feb;37(2):162-70
pubmed: 24347440
Cancer. 2012 Dec 1;118(23):5793-9
pubmed: 23640737
J Clin Oncol. 2008 Aug 1;26(22):3770-6
pubmed: 18669465
Folia Phoniatr Logop. 2002 Jul-Aug;54(4):171-6
pubmed: 12169803
Head Neck. 2013 Dec;35(12):1707-12
pubmed: 24142523
Dysphagia. 2011 Jun;26(2):155-70
pubmed: 20623305
Oral Oncol. 2012 Apr;48(4):343-8
pubmed: 22130454
Dysphagia. 2016 Apr;31(2):195-205
pubmed: 26837612
Support Care Cancer. 2012 Mar;20(3):433-43
pubmed: 22205548
Laryngoscope. 2012 Aug;122(8):1789-95
pubmed: 22833307
Head Neck. 1999 Jan;21(1):1-11
pubmed: 9890345
Am J Cardiol. 1993 Sep 30;72(10):68D-74D
pubmed: 8213501

Auteurs

Margot Baudelet (M)

Department of Radiation Oncology, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Ghent, Belgium. Margot.Baudelet@UGent.be.
Faculty of Medicine and Health Sciences, Department of Human Structure and Repair, Ghent University, St. Pietersnieuwstraat 33, 9000, Ghent, Belgium. Margot.Baudelet@UGent.be.
Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1 Wilrijk, 2610, Antwerp, Belgium. Margot.Baudelet@UGent.be.

Leen Van den Steen (L)

Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1 Wilrijk, 2610, Antwerp, Belgium.
Department of Otolaryngology and Head and Neck Surgery - Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium.

Fréderic Duprez (F)

Department of Radiation Oncology, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
Faculty of Medicine and Health Sciences, Department of Human Structure and Repair, Ghent University, St. Pietersnieuwstraat 33, 9000, Ghent, Belgium.

Marc De Bodt (M)

Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1 Wilrijk, 2610, Antwerp, Belgium.
Department of Otolaryngology and Head and Neck Surgery - Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium.
Faculty of Medicine and Health Sciences, Department of Rehabilitation Sciences, Ghent University, St. Pietersnieuwstraat 33, 9000, Ghent, Belgium.

Sarah Deschuymer (S)

Department of Radiation Oncology, KU Leuven, University Hospitals Leuven, Leuven, Belgium.

Ann Goeleven (A)

Department of ENT, University Hospitals Leuven, Swallowing Clinic, Leuven, Belgium.
Department of Head and Neck Surgery, University Hospitals Leuven, Swallowing Clinic, Leuven, Belgium.

Isabel Hutsebaut (I)

Department of Radiation Oncology, AZ Sint-Jan General Hospital, Bruges, Belgium.

Steven Mariën (S)

Department of Otolaryngology and Head and Neck Surgery - Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium.

Sabine Meersschout (S)

Department of Radiation Oncology, AZ Sint-Jan General Hospital, Bruges, Belgium.

Daan Nevens (D)

Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1 Wilrijk, 2610, Antwerp, Belgium.
Department of Radiation Oncology, Iridium Kanker Netwerk, Antwerp, Belgium.
Multi-disciplinary Oncological Center Antwerp, Antwerp, Belgium.

Sandra Nuyts (S)

Department of Radiation Oncology, KU Leuven, University Hospitals Leuven, Leuven, Belgium.
Laboratory of Experimental Radiotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.

Marc Peeters (M)

Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1 Wilrijk, 2610, Antwerp, Belgium.
Multi-disciplinary Oncological Center Antwerp, Antwerp, Belgium.
Department Medical Oncology, Antwerp University Hospital, Antwerp, Belgium.

Pol Specenier (P)

Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1 Wilrijk, 2610, Antwerp, Belgium.
Department of Otolaryngology and Head and Neck Surgery - Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium.
Multi-disciplinary Oncological Center Antwerp, Antwerp, Belgium.

Michiel Van den Brekel (M)

Department of Head and Neck Oncology and Surgery, Antoni van Leeuwenhoek, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Faculty of Humanities, University of Amsterdam, Spui 21, 1012 WX, Amsterdam, The Netherlands.

Lisette van der Molen (L)

Department of Head and Neck Oncology and Surgery, Antoni van Leeuwenhoek, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Caroline Vandenbruaene (C)

Department of Speech-Language Pathology and Audiology, Sint-Jan General Hospital, Bruges, Belgium.

Olivier Vanderveken (O)

Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1 Wilrijk, 2610, Antwerp, Belgium.
Department of Otolaryngology and Head and Neck Surgery - Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium.
Multi-disciplinary Oncological Center Antwerp, Antwerp, Belgium.

Joost Van Dinther (J)

Department of Otorhinolaryngology, Sint-Augustinus Hospital, Antwerp, Belgium.

Carl Van Laer (C)

Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1 Wilrijk, 2610, Antwerp, Belgium.
Department of Otolaryngology and Head and Neck Surgery - Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium.
Multi-disciplinary Oncological Center Antwerp, Antwerp, Belgium.

Tom Vauterin (T)

Department of Otorhinolaryngology-Head and Neck Surgery, AZ Sint-Jan General Hospital, Bruges, Belgium.

Hilde Verstraete (H)

Department of Radiation Oncology, Iridium Kanker Netwerk, Antwerp, Belgium.
Multi-disciplinary Oncological Center Antwerp, Antwerp, Belgium.

Gwen Van Nuffelen (G)

Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1 Wilrijk, 2610, Antwerp, Belgium.
Department of Otolaryngology and Head and Neck Surgery - Rehabilitation Center for Communication Disorders, Antwerp University Hospital, Antwerp, Belgium.
Faculty of Medicine and Health Sciences, Department of Rehabilitation Sciences, Ghent University, St. Pietersnieuwstraat 33, 9000, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH